Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study

Abstract

Rationale:

Research involving humans is regulated by regulatory authorities through their specific requirements and controls. The Healthy Life Style in Europe by Nutrition in Adolescence Cross-Sectional Study (HELENA-CSS) is a multicenter biomedical research study of adolescents in several representative European cities, which requires satisfying medico-regulatory requirements including Independent Ethics Committee (IEC) approval and agreement by the national or local regulatory authorities. To achieve a high level of quality assurance relating to ethical issues, we followed the good clinical practices (GCP) described at the International Conference on Harmonisation (ICH), which we adapted to the national and local situations of each of the 11 participating cities in 10 European countries.

Objective:

The main objective of the HELENA-CSS is to evaluate reliable and comparable data of nutritional habits and lifestyle in a representative sample of European adolescents. The aim of this paper is to present the methods relating to the ethical and regulatory issues of this study and to describe the current state of the medico-regulatory requirements involved in conducting this kind of study in each country.

Materials and Methods:

Following the GCP–ICH guidelines, a protocol describing the HELENA-CSS was written and approved by all partners. In the pilot study, a case report form adapted to the study objectives and its manual of operation was constructed and used by all partners. All information letters to adolescents and their parents and consent forms were first written in English, then translated into the local language, and adapted to each local situation. All documents were then checked centrally for any deviation and corrected if required. An operation manual relating to ethical issues and other medico-regulatory requirements was also developed. This paper presents the current status of the medico-regulatory requirements from each HELENA-CSS participant country.

Results:

Before the beginning of the study, most centers had satisfied the medico-regulatory requirements of IEC approval and agreement with other national or local regulatory authorities/organizations. For a few centers, some problems were detected and corrective actions were taken to improve missing information to reach a high level of quality assurance of ethical issues.

Conclusion:

The GCP–ICH guidelines about nontherapeutic biomedical research are interpreted and applied differently across Europe. This study shows that high-quality nontherapeutic biomedical research can address the ethical issues included in the GCP–ICH regulations and can be harmonized among the HELENA European partners.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Permissible medical experiments: trials of war criminals before the Nuremberg, Military Tribunals under Control Council Law No. 10: Nuremberg October 1946–1949 US Government Printing Office (DHEW publication): Washington, DC, 1979.

  2. World Medical Association. Recommendations guiding medical doctors in biomedical research involving human subjects. Helsinki: 18th World Assembly, 1964. Revised 52nd WMA World General Assembly, Edinburgh, Scotland, 2000.

  3. European Parliament Directive 2001/20/CE of the European Parliament and Council of 4 April 2001. Official Journal 2001; L121: 34–44.

  4. Royal College of Paediatrics and Child heath: Ethics Advisory Committee. Guidelines for the ethical conduct of medical research involving children. Arch Dis Child 2000; 82: 177–182.

    Article  Google Scholar 

  5. Silverman HJ, Druml C, Lemaire F, Nelson R . The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis. Intensive Care Med 2004; 25: 1723–1729.

    Google Scholar 

  6. National Commission for the Protection of Human Subjects of Biomedical and Behavorial Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. US Government Printing Office: Washington, DC, 1979.

  7. European Forum for Good Clinical Practices. The procedure for the ethical review of protocols for clinical research projects in the European Union. Int J Pharma Med 2007; 21: 1–113.

    Google Scholar 

  8. Demotes-Mainard J, Ohmann C . European Clinical Research Infrastructure Network: promoting harmonisation and quality in European clinical research. Lancet 2005; 365: 107–108.

    Article  Google Scholar 

  9. Demotes-Mainard J . Towards a European Clinical Research Infrastructures Network: the ECRIN programme. Thérapie 2004; 59: 151–153.

    Article  Google Scholar 

  10. Nelson RM, Reynolds WW . Child assent and parental permission: a comment on Tait's ‘Do they understand? Anesthesiology 2003; 98: 1–2.

    Article  Google Scholar 

  11. Miller VA, Drotar D, Kodish E . Children's competence for assent and consent: a review of empirical findings. Ethics Behav 2004; 14: 255–295.

    Article  Google Scholar 

  12. Miller VA, Nelson RR . A developmental approach to child assent for nontherapeutic research. J Pediatr 2006; 149: 525–530.

    Article  Google Scholar 

  13. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W . False hopes and best data: consent to research and the therapeutic misconception. Hastings Center Report 1987; 17: 20–24.

    Article  CAS  Google Scholar 

  14. Parnowski KJ, Allen DM, Mayhall C, Kelly PA . Readibility of pediatric biomedical research informed consent forms. Pediatrics 1990; 85: 58–62.

    Google Scholar 

  15. Ekunwe EO, Kessel R . Informed consent in the developing world. Hastings Center Report 1984; 14: 22–24.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The HELENA Study takes place with the financial support of the European Community Sitxth RTD Framework Programme (Contract FOOD-CT-20056007034). The content of this paper reflect only the authors’ views and the European Community is not liable for any use that may be made of the information contained therein. The researchers from the University of Zaragoza, Spain (MIM, LAM) are complementary supported by FUNDACIÓN MAPFRE (Spain).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to L Béghin.

Additional information

Conflict of interest

Frédéric Gottrand has received consulting fees from Numico Clinical Nutrition, lecture fees from SMS and grant support from Danone Research. The remaining authors state no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Béghin, L., Castera, M., Manios, Y. et al. Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study. Int J Obes 32 (Suppl 5), S12–S18 (2008). https://doi.org/10.1038/ijo.2008.179

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.179

Keywords

This article is cited by

Search

Quick links